SCOPUS 정보 검색 플랫폼

Volumn 6, Issue 5, 2011, Pages 947-950

EGFR gene alterations in a norwegian cohort of lung cancer patients selected for surgery

(11) Helland, Åslaug a,b Skaug, Hege Marian a Kleinberg, Lilach a Iversen, Marius Lund a Rud, Ane Kongsgaard a Fleischer, Thomas a Sagerup, Camilla a Solberg, Steinar a Jørgensen, Lars a Ariansen, Sarah a Brustugun, Odd Terje a,b

a OSLO UNIVERSITY HOSPITAL (Norway)

b UNIVERSITY OF OSLO (Norway)

Author keywords

Caucasian; EGFR mutations; Frequency; Lung cancer

Indexed keywords

EPIDERMAL GROWTH FACTOR RECEPTOR;

ADULT; AGED; ARTICLE; CANCER PATIENT; CANCER STAGING; CIGARETTE SMOKING; COHORT ANALYSIS; DENATURING HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; EXON; FEMALE; GENE DELETION; GENE MUTATION; GENE SEQUENCE; HUMAN; HUMAN CELL; HUMAN TISSUE; LUNG ADENOCARCINOMA; LUNG ALVEOLUS CELL CARCINOMA; LUNG SQUAMOUS CELL CARCINOMA; MAJOR CLINICAL STUDY; MALE; NORWAY; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL;

EID: 79955456047 PISSN: 15560864 EISSN: 15561380 Source Type: Journal
DOI: 10.1097/JTO.0b013e31820db209 Document Type: Article

Times cited : (43)

References (10)

1
- 2342471392
- Activating mutations in the epidermal growth factor receptor underlying responsiveness of non-small-cell lung cancer to gefitinib
- DOI 10.1056/NEJMoa040938
- Lynch TJ, Bell DW, Sordella R, et al. Activating mutations in the epidermal growth factor receptor underlying responsiveness of non-small-cell lung cancer to gefitinib. N Engl J Med 2004;350:2129-2139. (Pubitemid 38637993)
- (2004) New England Journal of Medicine , vol.350 , Issue.21 , pp. 2129-2139
- Lynch, T.J.¹ Bell, D.W.² Sordella, R.³ Gurubhagavatula, S.⁴ Okimoto, R.A.⁵ Brannigan, B.W.⁶ Harris, P.L.⁷ Haserlat, S.M.⁸ Supko, J.G.⁹ Haluska, F.G.¹⁰ Louis, D.N.¹¹ Christiani, D.C.¹² Settleman, J.¹³ Haber, D.A.¹⁴

2
- 2342624080
- EGFR mutations in lung, cancer: Correlation with clinical response to gefitinib therapy
- DOI 10.1126/science.1099314
- Paez JG, Janne PA, Lee JC, et al. EGFR mutations in lung cancer: correlation with clinical response to gefitinib therapy. Science 2004;304: 1497-1500. (Pubitemid 38720929)
- (2004) Science , vol.304 , Issue.5676 , pp. 1497-1500
- Paez, J.G.¹ Janne, P.A.² Lee, J.C.³ Tracy, S.⁴ Greulich, H.⁵ Gabriel, S.⁶ Herman, P.⁷ Kaye, F.J.⁸ Lindeman, N.⁹ Boggon, T.J.¹⁰ Naoki, K.¹¹ Sasaki, H.¹² Fujii, Y.¹³ Eck, M.J.¹⁴ Sellers, W.R.¹⁵ Johnson, B.E.¹⁶ Meyerson, M.¹⁷

3
- 4444344330
- EGF receptor gene mutations are common in lung cancers from "never smokers" and are associated with sensitivity of tumors to gefitinib and erlotinib
- DOI 10.1073/pnas.0405220101
- Pao W, Miller V, Zakowski M, et al. EGF receptor gene mutations are common in lung cancers from "never smokers" and are associated with sensitivity of tumors to gefitinib and erlotinib. Proc Natl Acad Sci USA 2004;101:13306-13311. (Pubitemid 39209661)
- (2004) Proceedings of the National Academy of Sciences of the United States of America , vol.101 , Issue.36 , pp. 13306-13311
- Pao, W.¹ Miller, V.² Zakowski, M.³ Doherty, J.⁴ Politi, K.⁵ Sarkaria, I.⁶ Singh, B.⁷ Heelan, R.⁸ Rusch, V.⁹ Fulton, L.¹⁰ Mardis, E.¹¹ Kupfer, D.¹² Wilson, R.¹³ Kris, M.¹⁴ Varmus, H.¹⁵

4
- 69949162760
- Gefitinib or carboplatinpaclitaxel in pulmonary adenocarcinoma
- Mok TS, Wu YL, Thongprasert S, et al. Gefitinib or carboplatinpaclitaxel in pulmonary adenocarcinoma. N Engl J Med 2009;361:947-957.
- (2009) N Engl J Med , vol.361 , pp. 947-957
- Mok, T.S.¹ Wu, Y.L.² Thongprasert, S.³

5
- 69949186250
- Screening for epidermal growth factor receptor mutations in lung cancer
- Rosell R, Moran T, Queralt C, et al. Screening for epidermal growth factor receptor mutations in lung cancer. N Engl J Med 2009;361:958-967.
- (2009) N Engl J Med , vol.361 , pp. 958-967
- Rosell, R.¹ Moran, T.² Queralt, C.³

6
- 24744438887
- Mutations in the tyrosine kinase domain of the EGFR gene associated with gefitinib response in non-small-cell lung cancer
- DOI 10.1016/j.lungcan.2005.05.017, PII S0169500205002497
- Rosell R, Ichinose Y, Taron M, et al. Mutations in the tyrosine kinase domain of the EGFR gene associated with gefitinib response in nonsmall- cell lung cancer. Lung Cancer 2005;50:25-33. (Pubitemid 41297466)
- (2005) Lung Cancer , vol.50 , Issue.1 , pp. 25-33
- Rosell, R.¹ Ichinose, Y.² Taron, M.³ Sarries, C.⁴ Queralt, C.⁵ Mendez, P.⁶ Sanchez, J.M.⁷ Nishiyama, K.-I.⁸ Moran, T.⁹ Cirauqui, B.¹⁰ Mate, J.L.¹¹ Besse, B.¹² Reguart, N.¹³ Perez, M.¹⁴ Sanchez, J.J.¹⁵

7
- 33845382806
- Nonparametric estimation from incomplete observations
- Kaplan EL, Meier P. Nonparametric estimation from incomplete observations. J Am Stat Assoc 1958;53:457-481.
- (1958) J Am Stat Assoc , vol.53 , pp. 457-481
- Kaplan, E.L.¹ Meier, P.²

8
- 10844231985
- Mutations of the epidermal growth factor receptor gene in lung cancer: Biological and clinical implications
- DOI 10.1158/0008-5472.CAN-04-2818
- Kosaka T, Yatabe Y, Endoh H, et al. Mutations of the epidermal growth factor receptor gene in lung cancer: biological and clinical implications. Cancer Res 2004;64:8919-8923. (Pubitemid 39665498)
- (2004) Cancer Research , vol.64 , Issue.24 , pp. 8919-8923
- Kosaka, T.¹ Yatabe, Y.² Endoh, H.³ Kuwano, H.⁴ Takahashi, T.⁵ Mitsudomi, T.⁶

9
- 77953158526
- High efficacy of first-line gefitinib in non-Asian patients with EGFR-mutated lung adenocarcinoma
- Moiseyenko VM, Procenko SA, Levchenko EV, et al. High efficacy of first-line gefitinib in non-Asian patients with EGFR-mutated lung adenocarcinoma. Onkologie 2010;33:231-238.
- (2010) Onkologie , vol.33 , pp. 231-238
- Moiseyenko, V.M.¹ Procenko, S.A.² Levchenko, E.V.³

10
- 85206957112
- Number 5, May
- Helland et al. Journal of Thoracic Oncology • Volume 6, Number 5, May 2011
- (2011) Journal of Thoracic Oncology • , vol.6
- Et Al., H.¹

* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.